Literature DB >> 21468742

Blonanserin's interesting food-effect observations: is lymphatic transport involved?

Nuggehally R Srinivas.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21468742     DOI： 10.1007/s00228-011-1039-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism.

Authors:  Natalie L Trevaskis; David M Shackleford; William N Charman; Glenn A Edwards; Anne Gardin; Silke Appel-Dingemanse; Olivier Kretz; Bruno Galli; Christopher J H Porter
Journal:  Pharm Res       Date:  2009-03-12       Impact factor: 4.200

2.  The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen.

Authors:  Werner Weitschies; Annika Bernsdorf; Thomas Giessmann; Michael Zschiesche; Christiane Modess; Vera Hartmann; Claudia Mrazek; Danilo Wegner; Stefan Nagel; Werner Siegmund
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

Review 3.  Intestinal lymphatic drug transport: an update.

Authors:  C J Porter; W N Charman
Journal:  Adv Drug Deliv Rev       Date:  2001-08-23       Impact factor: 15.470

4.  The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623).

Authors:  Natalie L Trevaskis; Claire L McEvoy; Michelle P McIntosh; Glenn A Edwards; Ravi M Shanker; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2010-03-11       Impact factor: 4.200

5.  Effect of dose timing in relation to food intake on systemic exposure to blonanserin.

Authors:  Junji Saruwatari; Norio Yasui-Furukori; Yoshimasa Inoue; Sunao Kaneko
Journal:  Eur J Clin Pharmacol       Date:  2010-05-20       Impact factor: 2.953

6.  Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220.

Authors:  Pavel Gershkovich; Bashir Qadri; Avihai Yacovan; Shimon Amselem; Amnon Hoffman
Journal:  Eur J Pharm Sci       Date:  2007-05-05       Impact factor: 4.384

Review 7.  Intestinal lipid absorption.

Authors:  Jahangir Iqbal; M Mahmood Hussain
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-21       Impact factor: 4.310
  7 in total
  1 in total

1.  Effects of food and grapefruit juice on single-dose pharmacokinetics of blonanserin in healthy Chinese subjects.

Authors:  De-Wei Shang; Zhan-Zhang Wang; Hai-Tang Hu; Yue-Feng Zhang; Xiao-Jia Ni; Hao-Yang Lu; Ming Zhang; Jin-Qing Hu; Chang Qiu; Huan Peng; Ling-Fang Shen; Yu-Guan Wen
Journal:  Eur J Clin Pharmacol       Date:  2017-10-03       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.